Evolent Health, Inc. (EVH)

NYSE: EVH · USD

$4.32

-0.10 (-2.3%)· Recorded snapshot

Market cap	488.4M
Revenue (ttm)	2.1B
Net income (ttm)	-511.1M
EPS (ttm)	-$4.54
Shares out	113.1M
P/E (forward)	12.2x
Volume	1,230,813
Beta	1.02

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 2.1B
Net income (ttm): -511.1M
EPS (ttm): -$4.54
P/E (forward): 12.2x
Market cap: 488.4M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Aanhouden

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E12.2

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-67

P25 n/aP50 n/aP75 n/a

ROIC-2.2

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All EVH indicators

Market & fundamental data

Available fields

229

Groups with data

Currency

USD

Showing 229 of 229 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001628908
Company name	Evolent Health, Inc.
Country	United States
Country code	US
CUSIP number	30050B101
Earnings date	2026-11-05
Earnings time	bmo
Employees	4,200
Employees change	-300
Employees growth	-6.67%
Enterprise value	$1.3B
Exchange	NYSE
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2011
In index	RUSSELL2000
Industry	Health Information Services
IPO date	2015-06-05
Is primary listing	Yes
Is SPAC	No
ISIN number	US30050B1017
Last 10-K release date	2026-02-25
Last earnings date	2026-08-06
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$488.4M
Market cap category	Small-Cap
Next earnings date	2026-11-05
Options	Yes
Price	$4.32
Price currency	USD
Sector	Healthcare
SIC code	8741
Stock price date	2026-10-28
Symbol	EVH
U.S. state	Virginia
Website	https://www.evolent.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	33.23x
Earnings yield	-105.14%
EV/EBITDA	22.04x
EV/FCF	58.64x
EV/Sales	0.64x
FCF / EV yield	1.71%
FCF yield	4.68%
Forward EV/Sales	0.43x
Forward P/E	12.22x
Forward P/S	0.16x
Industry forward P/E	34.62x
P/(OCF - SBC) ratio	43.09x
P/B ratio	1.3x
P/FCF ratio	21.39x
P/OCF ratio	9.03x
P/S ratio	0.23x
Price/EBITDA ratio	8.04x
Sector forward P/E	23.56x
Sector P/E	50.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-1.33%
EBITDA margin	2.91%
FCF margin	1.09%
Gross margin	17.25%
Operating margin	-1.33%
Pretax margin	-23.95%
Profit margin	-24.08%
Profit per employee	$-121,680
Revenue per employee	$499,290
ROA	-0.78%
ROA (5Y)	-0.14%
ROCE	-1.88%
ROE	-66.97%
ROE (5Y)	-17.87%
ROIC	-2.25%
ROIC (5Y)	-0.52%
SBC / revenue	2.05%
Tax / revenue	0.14%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	2
EPS growth years	0
Gross profit growth	0.66%
Gross profit growth (Q)	-19.47%
Gross profit growth 3Y	-3.58%
Gross profit growth 5Y	8.85%
Net income growth quarters	2
Net income growth years	0
OCF growth 3Y	29.68%
Revenue growth	-4.5%
Revenue growth (Q)	46.86%
Revenue growth (QoQ)	31.49%
Revenue growth 10Y	26.98%
Revenue growth 3Y	8.72%
Revenue growth 5Y	17.83%
Revenue growth quarters	2
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-31.4M
Depreciation and amortization	$88.9M
EBIT	$-27.8M
EBITDA	$61M
EPS	$-4.54
FCF per share	$0.20
Financing cash flow	$-149.8M
Free cash flow	$22.9M
Free cash flow minus SBC	$-20M
Gross profit	$361.6M
Income taxes	$2.9M
Investing cash flow	$60.3M
Net borrowing	$-103.4M
Net cash flow	$-36.5M
Net income	$-511.1M
Operating cash flow minus SBC	$11.4M
Operating income	$-27.8M
Revenue	$2.1B
Stock-based compensation	$42.9M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	0.36
Book value per share	$3.40
Debt / EBITDA	14.99
Debt / equity	2.53
Debt / FCF	42.3
Goodwill	$694.4M
Interest coverage	-0.4
Long-term assets	$1.4B
Long-term liabilities	$1.1B
Net cash (debt)	$-854.7M
Net cash / market cap	-174.19%
Net debt / EBITDA	14
Net debt / equity	2.23
Net debt / FCF	37.26
Piotroski F-Score	5
Property, plant and equipment	$4.9M
Shareholders' equity	$383.2M
Tangible book value	$-945.3M
Tangible book value per share	$-8.39
Total assets	$2B
Total cash	$115.7M
Total debt	$970.4M
Total liabilities	$1.6B
WACC	7.06%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.95
Current assets	$610.5M
Current liabilities	$492.8M
Current ratio	1.24
Net working capital	$3.5M
Quick ratio	1.15
Working capital	$117.7M
Working capital turnover	34.26

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	2.39%
Dividend yield	0%
Shareholder yield	2.39%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-79.42%
10Y return CAGR	-14.63%
10Y total return	-79.42%
150-day SMA	$4.12
1D price change	-2.26%
1M price change	18.84%
1M total return	18.84%
1W price change	-11.91%
1W total return	-11.91%
1Y price change	-43.85%
1Y return CAGR	-43.87%
1Y total return	-43.85%
20-day SMA	$4.33
200-day SMA	$3.87
3M price change	12.6%
3M total return	12.6%
3Y price change	-82.11%
3Y return CAGR	-43.65%
3Y total return	-82.11%
50-day SMA	$4.21
50-day SMA vs 200-day SMA	50over200
52-week high	$7.66
52-week high date	2025-10-28
52-week low	$2.10
52-week low date	2026-04-02
5Y price change	-85.08%
5Y return CAGR	-31.65%
5Y total return	-85.08%
6M price change	23.63%
6M total return	23.63%
All-time high	$39.78
All-time high date	2022-09-15
All-time low	$2.10
All-time low date	2026-04-02
Average true range (ATR)	$0.27
Average volume	1.8M
Beta (1Y)	2.36
Beta (2Y)	0.48
Beta (5Y)	1.02
Change from 52-week high	-43.57%
Change from 52-week low	106.21%
Change from all-time high	-89.22%
Change from all-time low	104.77%
Change from open	-3.03%
Day's gap	0.79%
Dollar volume	$5.3M
High price	$4.46
Low price	$4.27
Monthly RSI	39.37
Open price	$4.46
Position in 52-week range	27.03%
Premarket change	-0.45%
Premarket close	$4.42
Premarket price	$4.40
Previous close	$4.42
Price vs 150-day SMA	4.25%
Price vs 20-day SMA	-0.9%
Price vs 200-day SMA	10.97%
Price vs 50-day SMA	1.92%
Relative volume	0.68
RSI	48.84
Sharpe ratio	-0.37
Sharpe ratio (3Y)	-0.5
Sharpe ratio (5Y)	-0.34
Sortino ratio	-0.47
Sortino ratio (3Y)	-0.62
Sortino ratio (5Y)	-0.39
Volume	1.2M
Weekly RSI	50.08
YTD price change	7.25%
YTD total return	7.25%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	94.2M
Float percentage	83.34%
Shares change (QoQ)	0.57%
Shares change (YoY)	-2.39%
Shares held by insiders	1.95%
Shares held by institutions	82.61%
Shares outstanding	113.1M
Short % of float	13.7%
Short % of shares	11.42%
Short ratio	5.4 days

Deeper analysis on EVH

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this EVH report

Is a complete EVH research report available?

No complete published report is available for Evolent Health, Inc. (EVH) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Evolent Health, Inc. (EVH)

Price

Financial snapshot

Fair-value bridge

Latest news · EVH

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All EVH indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on EVH

Frequently asked questions